SHLA-DRB1 HED is associated with improved survival and decreased relapse in patients with hematologic malignancies following allogeneic hematopoietic stem cell transplant Meeting Abstract
| Authors: | Camacho-Bydume, C.; Wang, T.; Chowell, D.; Krishna, C.; Shaffer, B. C.; Marsh, S.; Paczesny, S.; Gadalla, S. M.; He, M.; Bolon, Y. T.; Spellman, S. R.; Lee, S. J.; Hsu, K. C. |
| Abstract Title: | SHLA-DRB1 HED is associated with improved survival and decreased relapse in patients with hematologic malignancies following allogeneic hematopoietic stem cell transplant |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 2232 |
| Language: | English |
| ACCESSION: | WOS:001159306708204 |
| DOI: | 10.1182/blood-2023-179543 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
